This Day On The Street
Continue to site
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

Span-America Reports Strong First Quarter Results

Span-America Medical Systems, Inc. (NASDAQ:SPAN) today reported record sales and strong growth in net income for the first quarter ended December 31, 2011. Net income for the first quarter of fiscal 2012 rose 57% to $1.1 million, or $0.39 per diluted share, compared with $717,000, or $0.25 per diluted share, in the first quarter of fiscal 2011. Net sales for the first quarter of fiscal 2012 increased 75% to $20.5 million compared with $11.7 million in the first quarter of fiscal 2011.

“Our record first quarter sales results came from increased demand for consumer bedding products during the holiday selling season and the addition of M.C. Healthcare Products that was acquired on December 9, 2011,” stated Jim Ferguson, president and chief executive officer of Span-America. “Sales in the custom products segment rose 197% to $11.1 million, and medical sales were up 18% to $9.4 million in the first quarter of fiscal 2012 compared with the first quarter of the prior fiscal year. Our medical sales benefited from the M.C. Healthcare acquisition from the closing date of December 9 th through the end of the quarter, which added approximately $1.0 million to our first quarter sales. Our new Custom Care® line of therapeutic support surfaces also contributed to medical sales growth during the quarter.

“Span-America’s earnings growth for the first quarter was driven mainly by the large increase in sales volume. We are pleased that our strong earnings and cash flow during the first quarter allowed us to reduce long-term debt from a peak of $7.0 million in mid-December to $1.0 million by the end of the quarter,” continued Mr. Ferguson.

First Quarter Results

Sales for the first quarter of fiscal 2012 increased 75% to $20.5 million compared with $11.7 million in the first quarter of fiscal 2011. The majority of the sales growth came from the custom products segment, where sales almost tripled to $11.1 million compared with $3.7 million in the first quarter of fiscal 2011. Total medical sales increased 18% to $9.4 million for the first quarter of fiscal 2012, including $1.0 million of M.C. Healthcare sales. Excluding the M.C. Healthcare acquisition, sales in the medical segment increased 5% to $8.4 million during the first quarter of fiscal 2012 compared with $8.0 million in the first quarter last fiscal year.

1 of 5

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Real Money

More than 30 investing pros with skin in the game give you actionable insight and investment ideas.

Product Features:
  • Access to Jim Cramer's daily blog
  • Intraday commentary and news
  • Real-time trading forums
Only $49.95
14-Days Free
14-Days Free
AAPL $94.99 -0.02%
FB $99.54 -0.21%
GOOG $678.11 -0.68%
TSLA $148.25 0.18%
YHOO $26.82 -0.85%


Chart of I:DJI
DOW 16,014.38 -12.67 -0.08%
S&P 500 1,852.21 -1.23 -0.07%
NASDAQ 4,268.7630 -14.99 -0.35%

Free Reports

Top Rated Stocks Top Rated Funds Top Rated ETFs